transact tech - TACT
TACT
Close Chg Chg %
3.91 0.25 6.39%
Closed Market
4.16
+0.25 (6.39%)
Volume: 103.57K
Last Updated:
Nov 22, 2024, 4:00 PM EDT
Company Overview: transact tech - TACT
TACT Key Data
Open $3.89 | Day Range 3.89 - 4.39 |
52 Week Range 3.32 - 7.97 | Market Cap $39.14M |
Shares Outstanding 10.01M | Public Float 9.10M |
Beta 1.75 | Rev. Per Employee N/A |
P/E Ratio N/A | EPS -$0.20 |
Yield 0.00% | Dividend $0.09 |
EX-DIVIDEND DATE Nov 19, 2019 | SHORT INTEREST N/A |
AVERAGE VOLUME 26.66K |
TACT Performance
1 Week | 3.48% | ||
1 Month | 0.24% | ||
3 Months | -6.52% | ||
1 Year | -41.03% | ||
5 Years | -62.32% |
TACT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
About transact tech - TACT
TransAct Technologies, Inc. engages in the operation of a software-driven technology and printing solutions company. The company was founded in June 1996 and is headquartered in Hamden, CT.
TACT At a Glance
TransAct Technologies, Inc.
One Hamden Center
Hamden, Connecticut 06518
Phone | 1-203-859-6800 | Revenue | 72.63M | |
Industry | Computer Peripherals | Net Income | 4.75M | |
Sector | Electronic Technology | 2023 Sales Growth | 24.926% | |
Fiscal Year-end | 12 / 2024 | Employees | 117 | |
View SEC Filings |
TACT Valuation
P/E Current | N/A |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | 14.732 |
Price to Sales Ratio | 0.963 |
Price to Book Ratio | 1.764 |
Price to Cash Flow Ratio | 12.701 |
Enterprise Value to EBITDA | 8.551 |
Enterprise Value to Sales | 0.847 |
Total Debt to Enterprise Value | 0.063 |
TACT Efficiency
Revenue/Employee | 620,777.778 |
Income Per Employee | 40,581.197 |
Receivables Turnover | 7.393 |
Total Asset Turnover | 1.363 |
TACT Liquidity
Current Ratio | 3.007 |
Quick Ratio | 1.704 |
Cash Ratio | 0.904 |
TACT Profitability
Gross Margin | 51.032 |
Operating Margin | 7.856 |
Pretax Margin | 8.127 |
Net Margin | 6.537 |
Return on Assets | 8.911 |
Return on Equity | 12.959 |
Return on Total Capital | 10.962 |
Return on Invested Capital | 12.548 |
TACT Capital Structure
Total Debt to Total Equity | 9.892 |
Total Debt to Total Capital | 9.002 |
Total Debt to Total Assets | 7.156 |
Long-Term Debt to Equity | 1.827 |
Long-Term Debt to Total Capital | 1.662 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Transact Tech - TACT
Collapse All in section
All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
---|---|---|---|---|---|
Sales/Revenue
| 30.59M | 39.39M | 58.14M | 72.63M | |
Sales Growth
| -33.12% | +28.73% | +47.61% | +24.93% | |
Cost of Goods Sold (COGS) incl D&A
| 17.67M | 24.14M | 33.73M | 35.57M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 1.34M | 957.00K | 1.33M | 1.49M | |
Depreciation
| 1.11M | 771.00K | 1.18M | 1.33M | |
Amortization of Intangibles
| 234.00K | 186.00K | 155.00K | 154.00K | |
COGS Growth
| -25.81% | +36.63% | +39.73% | +5.45% | |
Gross Income
| 12.93M | 15.25M | 24.41M | 37.06M | |
Gross Income Growth
| -41.06% | +17.94% | +60.09% | +51.83% | |
Gross Profit Margin
| +42.26% | +38.72% | +41.99% | +51.03% |
2020 | 2021 | 2022 | 2023 | 5-year trend | |
---|---|---|---|---|---|
SG&A Expense
| 21.10M | 24.76M | 32.09M | 31.36M | |
Research & Development
| 5.70M | 7.47M | 8.57M | 8.11M | |
Other SG&A
| 15.40M | 17.28M | 23.52M | 23.25M | |
SGA Growth
| -2.27% | +17.33% | +29.61% | -2.27% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | (2.17M) | - |
EBIT after Unusual Expense
| (8.17M) | (7.34M) | (7.68M) | 5.71M | |
Non Operating Income/Expense
| 134.00K | 1.28M | (16.00K) | 507.00K | |
Non-Operating Interest Income
| - | 78.00K | 61.00K | 55.00K | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 130.00K | 157.00K | 208.00K | 310.00K | |
Interest Expense Growth
| +364.29% | +20.77% | +32.48% | +49.04% | |
Gross Interest Expense
| 130.00K | 157.00K | 208.00K | 310.00K | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (8.17M) | (6.22M) | (7.90M) | 5.90M | |
Pretax Income Growth
| -2,325.89% | +23.91% | -27.11% | +174.71% | |
Pretax Margin
| -26.70% | -15.78% | -13.59% | +8.13% | |
Income Tax
| (2.54M) | (2.07M) | (1.97M) | 1.16M | |
Income Tax - Current - Domestic
| (2.12M) | 77.00K | 259.00K | 50.00K | |
Income Tax - Current - Foreign
| (48.00K) | 2.00K | (83.00K) | 85.00K | |
Income Tax - Deferred - Domestic
| (519.00K) | (2.15M) | (2.14M) | 957.00K | |
Income Tax - Deferred - Foreign
| - | 152.00K | (2.00K) | 63.00K | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| (5.63M) | (4.14M) | (5.94M) | 4.75M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| (5.63M) | (4.14M) | (5.94M) | 4.75M | |
Net Income Growth
| -1,191.09% | +26.38% | -43.21% | +179.99% | |
Net Margin Growth
| -18.40% | -10.52% | -10.21% | +6.54% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (5.63M) | (4.14M) | (5.94M) | 4.75M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (5.63M) | (4.14M) | (5.94M) | 4.75M | |
EPS (Basic)
| -0.7193 | -0.4458 | -0.5993 | 0.4771 | |
EPS (Basic) Growth
| -1,140.96% | +38.02% | -34.43% | +179.61% | |
Basic Shares Outstanding
| 7.83M | 9.30M | 9.90M | 9.95M | |
EPS (Diluted)
| -0.7193 | -0.4458 | -0.5993 | 0.4738 | |
EPS (Diluted) Growth
| -1,170.39% | +38.02% | -34.43% | +179.06% | |
Diluted Shares Outstanding
| 7.83M | 9.30M | 9.90M | 10.02M | |
EBITDA
| (6.83M) | (8.55M) | (6.34M) | 7.20M | |
EBITDA Growth
| -498.54% | -25.21% | +25.82% | +213.40% | |
EBITDA Margin
| -22.33% | -21.72% | -10.91% | +9.91% |
Snapshot
Average Recommendation | BUY | Average Target Price | 6.75 | |
Number of Ratings | 2 | Current Quarters Estimate | -0.095 | |
FY Report Date | 12 / 2024 | Current Year's Estimate | -0.295 | |
Last Quarter’s Earnings | -0.06 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 0.59 | Next Fiscal Year Estimate | -0.095 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 2 | 2 | 2 | 2 |
Mean Estimate | -0.10 | -0.06 | -0.30 | -0.10 |
High Estimates | -0.09 | -0.06 | -0.29 | -0.02 |
Low Estimate | -0.10 | -0.06 | -0.30 | -0.17 |
Coefficient of Variance | -7.44 | 0.00 | -2.40 | -111.65 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 2 | 2 | 2 |
OVERWEIGHT | 0 | 0 | 0 |
HOLD | 0 | 0 | 0 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 0 | 0 | 0 |
MEAN | Buy | Buy | Buy |
SEC Filings for Transact Tech - TACT
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Transact Tech - TACT
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
May 7, 2024 | Audrey P. Dunning Director | 6,500 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 7, 2024 | Audrey P. Dunning Director | 3,400 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 7, 2024 | 325 Capital LLC Director | 5,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
May 7, 2024 | 325 Capital LLC Director | 3,400 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Apr 9, 2024 | John M. Dillon Director | 5,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 9, 2024 | John M. Dillon Director | 3,300 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Apr 9, 2024 | John M. Dillon Director | 62,300 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | John M. Dillon CEO; Director | 4,800 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | Brent Richtsmeier Chief Technology Officer | 1,950 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | John M. Dillon CEO; Director | 1,100 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | Emanuel P. N. Hilario Director | 13,750 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | John M. Dillon CEO; Director | 23,300 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 5, 2024 | Emanuel P. N. Hilario Director | 16,100 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | Emanuel P. N. Hilario Director | 6,700 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 5, 2024 | Emanuel P. N. Hilario Director | 4,800 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | Emanuel P. N. Hilario Director | 2,500 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | Emanuel P. N. Hilario Director | 1,100 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 5, 2024 | William J. DeFrances Chief Accounting Officer | 7,500 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 5, 2024 | John M. Dillon CEO; Director | 59,500 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 5, 2024 | Steven A. DeMartino President, CFO, Treas. & Secr. | 92,372 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |